<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - Repligen</title>
<description>International Business News - Repligen</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Repligen board OKs stock buyback plan</title>
  <description>Repligen Corp. said Wednesday its board authorized the repurchase of up to 1.3 million shares in the open market or private transactions. The biopharmaceutical company has 31.2 million shares outstanding, and the stock repurchases will be funded with available cash.</description>
    <link>http://www.ibtimes.com/articles/20080618/repligen-board-oks-stock-buyback-plan.htm</link> 
  <pubDate>Wed, 18 Jun 2008 14:53:15 EDT</pubDate>
  </item>


  <item>
  <title>Bristol-Myers and Repligen Corp. Settle Lawsuit with $5 Million</title>
  <description>Bristol-Myers Squibb Co. agreed today to pay $5 million plus royalties to Repligen Corp. to settle a patent infringement lawsuit for a rheumatoid arthritis treatment.</description>
    <link>http://www.ibtimes.com/articles/20080408/bristol-myers-repligen-orencia.htm</link> 
  <pubDate>Tue, 08 Apr 2008 18:22:06 EDT</pubDate>
  </item>


  <item>
  <title>Repligen: Bristol Settles Orencia Suit</title>
  <description>
Repligen Corp. said Tuesday that Bristol-Myers Squibb Co. agreed to pay $5 million plus royalties to settle a patent infringement lawsuit for a rheumatoid arthritis treatment.

Repligen&amp;#39;s suit, file...</description>
    <link>http://www.ibtimes.com/articles/20080408/repligen-bristol-settles-orencia-suit.htm</link> 
  <pubDate>Tue, 08 Apr 2008 07:47:15 EDT</pubDate>
  </item>


</channel>
</rss>